Recent insights and therapeutic perspectives of angiotensin-(1-9) in the cardiovascular system. (Q38230104)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029123%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Recent insights and therapeutic perspectives of angiotensin-(1-9) in the cardiovascular system (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029123%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

ChEBI release 2020-05-28

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029123%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Carlos F. Lagos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029123%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Maria Paz Ocaranza

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029123%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Luis Michea

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029123%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Sergio Lavandero

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029123%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Jorge E Jalil

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029123%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

language of work or name

English

0 references

publication date

1 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029123%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029123%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029123%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029123%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

549-557

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029123%20AND%20SRC:MED&resulttype=core&format=json

The prothrombotic paradox of hypertension: role of the renin-angiotensin and kallikrein-kinin systems

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Signal transduction from the angiotensin II AT2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Cardiovascular actions of angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Radioimmunoassay for immunoreactive [des-Leu10]-angiotensin I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Effect of chronic enalapril treatment on enzymes responsible for the catabolism of angiotensin I and formation of angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Angiotensin-(1-9) regulates cardiac hypertrophy in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Angiotensin 1-9 and 1-7 release in human heart: role of cathepsin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Hydrolysis of angiotensin peptides by human angiotensin I-converting enzyme and the resensitization of B2 kinin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

ACE2 of the heart: From angiotensin I to angiotensin (1-7)

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Network modeling reveals steps in angiotensin peptide processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Angiotensin1-9 antagonises pro-hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Angiotensin-(1-9) attenuates cardiac fibrosis in the stroke-prone spontaneously hypertensive rat via the angiotensin type 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Recent progress in angiotensin II type 2 receptor research in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Vasoactive peptides in cardiovascular (patho)physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Physiological and pathophysiological functions of the AT(2) subtype receptor of angiotensin II: from large arteries to the microcirculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Discovery and characterization of alamandine: a novel component of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

The effects of angiotensin II and specific angiotensin receptor blockers on embryonic cardiac development and looping patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Angiotensin II receptor blockers in pregnancy: a case report and systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Impact of AT2 receptor deficiency on postnatal cardiovascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Products of angiotensin I hydrolysis by human cardiac enzymes potentiate bradykinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Identification of membrane-bound variant of metalloendopeptidase neurolysin (EC 3.4.24.16) as the non-angiotensin type 1 (non-AT1), non-AT2 angiotensin binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Thimet oligopeptidase and oligopeptidase M or neurolysin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Molecular Cloning and Expression of Rat Brain Endopeptidase 3.4.24.16

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Targeting of endopeptidase 24.16 to different subcellular compartments by alternative promoter usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Pharmacological characterization of a novel non-AT1, non-AT2 angiotensin binding site identified as neurolysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Further characterization of a neurotensin-degrading neutral metalloendopeptidase from rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Purification of the main somatostatin-degrading proteases from rat and pig brains, their action on other neuropeptides, and their identification as endopeptidases 24.15 and 24.16

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Structure of neurolysin reveals a deep channel that limits substrate access

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Purification and characterization of human endopeptidase 3.4.24.16. Comparison with the porcine counterpart indicates a unique cleavage site on neurotensin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Neuropeptide specificity and inhibition of recombinant isoforms of the endopeptidase 3.4.24.16 family: comparison with the related recombinant endopeptidase 3.4.24.15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

New insights into angiotensin receptor actions: from blood pressure to aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

AT1 angiotensin II receptor and novel non-AT1, non-AT2 angiotensin II/III binding site in brainstem cardiovascular regulatory centers of the spontaneously hypertensive rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Cell signaling, internalization, and nuclear localization of the angiotensin converting enzyme in smooth muscle and endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Stimulation of ANP by angiotensin-(1-9) via the angiotensin type 2 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Impairment of In Vitro and In Vivo Heart Function in Angiotensin-(1-7) Receptor Mas Knockout Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Prevention of cardiac hypertrophy by angiotensin II type-2 receptor gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Angiotensin-(1-9) enhances stasis-induced venous thrombosis in the rat because of the impairment of fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Rho kinase inhibition activates the homologous angiotensin-converting enzyme-angiotensin-(1-9) axis in experimental hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Effects of angiotensin type 2 receptor overexpression in the rostral ventrolateral medulla on blood pressure and urine excretion in normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Angiotensin type 2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

The angiotensin II type 2 receptor and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Pressure natriuresis in AT(2) receptor-deficient mice with L-NAME hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Angiotensin II AT2 receptors inhibit proximal tubular Na+-K+-ATPase activity via a NO/cGMP-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

Study of angiotensin-(1-7) vasoactive peptide and its beta-cyclodextrin inclusion complexes: complete sequence-specific NMR assignments and structural studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130449

21 January 2018

Identifiers

DOI

10.1042/CS20130449

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029123%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference